TECH & INNOVATION

All Eyes on Palatin Technologies as Major Obesity Trial Results

All Eyes on Palatin Technologies as Major Obesity Trial Results Near

Palatin Technologies has completed its closely watched Phase 2 BMT-801 clinical trial, with results expected before the end of March 2025. The study, which drew unexpectedly strong interest from patients, enrolled 113 participants—nearly double its initial target of 60—across four U.S. clinical sites.
Ravi Kumar Vankayalapati

Autonomous Fault Recovery: A Transformative Approach Leveraging AI-Driven Self-Healing Cloud

As cloud computing continues to play a stellar role in digital transformation, the importance of building strong and flexible cloud infrastructure has increased significantly. Ravi Kumar Vankayalapati, a technology expert with proven expertise in enterprise-level architecture, has made significant contributions towards addressing these challenges by leading AI-driven innovations.
1 2 3 4 5 6 7 8 9

Recommended Stories